JPRN-UMIN000021669尚未招募未知
The impact of the SGLT2 inhibitor on cardiovascular risk factors in patients with type 2 diabetes, an explanatory randomized trial - The impact of the SGLT2 inhibitor on cardiovascular risk factors
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Diagnosed as diabetes within the last 6 months 2. Taking SGLT2 inhibitors 3. Taking diuretics 4. Pituitary dysfunction or adrenal insufficiency 5. Excessive alcohol intake 8. eGFR < 30mL / min / 1.73m2(MDRD) 9. AST >= 165 or ALT >= 210 10. Serum C-peptide < 0.5ng / mL 11. History of severe hypoglycemia within the last 3 months 12. Systolic blood pressure >= 200 mmHg or diastolic blood pressure >=120 mmHg 13. Secondary hypertension 14. Vitreous hemorrhage, unstable proliferative diabetic retinopathy 15. Severe diabetic neuropathy 16. Positive anti-GAD antibody 17. During pregnancy 18. Chronic atrial fibrillation 19. History of pyelonephritis 20. Claustrophobia, pacemaker, the metal in the body, weighing 150 kg or more 21. Unable to hold the breath longer than 20 seconds
研究者
相似试验
进行中（未招募）
1 期
SGLT-2 Inhibition, Metabolomics and Cardiovascular DiseaseType 2 Diabetes mellitusMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861EUCTR2017-005136-41-ESFundación Pública Andaluza para la Investigación de Málaga en Biomedicina Y Salud (FIMABIS)60
招募中
Unknown
To study the effect of a medication(SGLT 2 inhibitor) on the structural changes in the heart in patients with poor heart pumping and irregular heart rhythmCTRI/2023/08/056196Kasturba Medical College
招募中
不适用
Observation study to asses the effect of SGLT2 inhibitors on cardiac uptake of FDGEndocrine, nutritional and metabolic diseaseKCT0004869lsan Univeristy Hospital30
已完成
不适用
Study of the safety of SGLT-2 inhibitors for heart failure patients with type 2 diabetes mellitusheart failure patients with type 2 diabetes mellitusJPRN-UMIN000018996ippon Medical School Department of Cardiovascular Medicine20
进行中（未招募）
1 期
Effects of SGLT-2 inhibitor on heart function and metabolism in patients with Type 2 diabetes and high risk of heart disease cardiovascular: The SIMPle Randomized Clinical TrialType 2 diabetes and cardiovascular riskEUCTR2016-003743-10-DKHerlev og Gentofte Hospital92